Recent posts
Feds commit $3.2B to lock in Covid-19 vax provide forward of fall vaccination marketing campaign
The federal authorities has reached a deal to pay $3.2 billion to safe a brand new provide of the Pfizer/BioNTech Covid-19 vaccine that features photographs particularly tailored to the omicron variant. The settlement introduced late Wednesday covers t…
Read more
Ipsen’s $247M Epizyme acquisition brings authorised most cancers drug & extra in pipeline
Ipsen has been reshaping its drug lineup by placing offers and its newest one is a $247 million settlement to purchase Epizyme , a most cancers drug developer with one commercialized product and a pipeline of extra therapeutic candidates. The important …
Read more
Addressing the Stigmas of PTSD
Whereas June could also be Submit-Traumatic Stress Dysfunction (PTSD) Consciousness month, IU Well being makes it a yearlong focus working with sufferers who battle with PTSD day by day. It’s essential to deliver consciousness to PTSD as many individuals un…
Read more
With $110M in new funds, Aidoc is branching out of radiology
Aidoc , a startup greatest identified for offering AI-powered resolution help software program for radiologists, is branching out of the radiology market. The Tel Aviv-based firm closed a $110 million sequence D funding spherical on Thursday, bringing th…
Read more
Pfizer, Moderna Covid-19 vaccines are actually licensed for teenagers as younger as 6 months
The Pfizer and Moderna Covid-19 vaccines are actually licensed for youngsters as younger as 6 months outdated, an FDA resolution that clears the way in which for this final remaining age group to achieve entry to both of the pictures. These messenger RN…
Read more
As muscular dystrophy drug meets key purpose, Italfarmaco plans march ahead to regulators
Assessments of Duchenne muscular dystrophy medication sometimes assess how sufferers with the muscle-wasting dysfunction performs duties, corresponding to strolling. The important thing measure in a pivotal check of Italfarmaco Group’s Duchenne drug, giv…
Read more
MedShift CEO shares imaginative and prescient for progress
When he stepped into the CEO function at MedShift in November 2021, Joe Gasque knew it will be one thing of a balancing act. He sees his function as serving to to keep up the corporate’s speedy progress whereas establishing a framework to construct on hig…
Read more
